Resumo
Definição
História e exame físico
Principais fatores diagnósticos
- presença de fatores de risco
- assintomático
Outros fatores diagnósticos
- corrimento cervical
- colo uterino friável
- abnormal vaginal bleeding
- secreção peniana
- corrimento vaginal
- disúria
- dor pélvica
- febre/calafrios
- náuseas/vômitos
- dor escrotal
- mialgias
- dor abdominal
- corrimento retal mucopurulento ou tenesmo
- Dor nas articulações e edema
- irritação ocular
- erupções cutâneas
- inflamação
Fatores de risco
- idade abaixo de 25 anos, sexualmente ativo
- múltiplos ou novos parceiros sexuais
- atividade sexual com parceiro infectado
- não utilização de preservativos
- história de IST prévia
- etnia
- residência urbana e baixa condição socioeconômica
Investigações diagnósticas
Primeiras investigações a serem solicitadas
- teste de amplificação de ácido nucleico (NAAT)
Investigações a serem consideradas
- imunofluorescência direta
- ensaio imunoenzimático
- testes de hibridização de ácido nucleico
- cultura celular
Novos exames
- testes rápidos e testes laboratoriais remotos
Algoritmo de tratamento
confirmada ou suspeita
Colaboradores
Autores
Matthew M. Hamill, MBChB, PhD, FRCP
Assistant Professor of Medicine
Johns Hopkins University School of Medicine
Baltimore
MD
Declarações
MMH receives royalties for contributing to UpToDate on Lymphogranuloma venereum and for Clinical Care Options. He has an honorarium from Roche Diagnostics for panel STI & HIV 2021 World Congress (virtual) and was a member of the 2021 Roche group on future of POCT for STI. He has also received consulting fees from GSK for the HSV vaccine.
Agradecimentos
Dr Matthew M. Hamill would like to gratefully acknowledge Dr Anne Rompalo and Dr Christopher K. Fairley, the previous contributors to this topic.
Declarações
AR and CKF declare that they have no competing interests.
Revisores
Kenneth Lin, MD
Assistant Editor
American Family Physician
Clinical Assistant Professor
GUSOM Medical Officer
US Preventive Services Task Force
Disclosures
KL declares that he has no competing interests.
Lars Jørgen Østergaard, MD, PhD, DMSc
Professor/Head
Department of Infectious Diseases
Aarhus University Hospital
Skejby Sygehus
Aarhus
Denmark
Disclosures
LJO has been funded by Pfizer to write a leaflet on Chlamydia infections.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
References
Key articles
Nwokolo NC, Dragovic B, Patel S, et al. 2015 UK national guideline for the management of infection with Chlamydia trachomatis. Int J STD AIDS. 2016 Mar;27(4):251-67.Full text Abstract
Centers for Disease Control and Prevention. Sexually transmitted infections surveillance, 2023. Nov 2024 [internet publication].Full text
Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021 Jul 23;70(4):1-187.Full text Abstract
US Preventive Services Task Force. Final recommendation statement. Chlamydia and gonorrhea: screening. Sept. 2021 [internet publication].Full text
Geisler WM, Uniyal A, Lee JY, et al. Azithromycin versus doxycycline for urogenital chlamydia trachomatis Infection. N Engl J Med. 2015 Dec 24;373(26):2512-21.Full text Abstract
American College of Obstetricians and Gynecologists. Committee opinion no. 737: expedited partner therapy. Jun 2018 [internet publication].Full text
Reference articles
A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
Differentials
- Linfogranuloma venéreo
- Infecção por gonorreia
- Vaginose bacteriana
More DifferentialsGuidelines
- 2025 European guideline on the management of Chlamydia trachomatis infections
- Reducing sexually transmitted infections
More GuidelinesPatient information
Clamídia
More Patient informationLog in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer